Pharmacokinetics and Tolerability of Single-dose Intravenous Ertapenem in Infants, Children, and Adolescents-Reference-Cited by-同舟云学术

Pharmacokinetics and Tolerability of Single-dose Intravenous Ertapenem in Infants, Children, and Adolescents

Published:2010-12 Issue:12 Volume:29 Page:1072-1076
ISSN:0891-3668
Container-title:Pediatric Infectious Disease Journal
language:en
Short-container-title:

Author:

Abdel-Rahman Susan M.,Kearns Gregory L.,Topelberg Santiago,Jacobs Richard F.,Mistry Goutam C.,Majumdar Anup,Xu Yang,Wagner John A.,Kitchen Chester J.,Groff Michelle,Herman Gary,Blumer Jeffrey L.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Microbiology (medical),Pediatrics, Perinatology, and Child Health

Reference20 articles.

1. Ertapenem: a group 1 carbapenem with distinct antibacterial and pharmacological properties.;Hammond;J Antimicrob Chemother,2004

2. Properties and potential of ertapenem.;Livermore;J Antimicrob Chemother,2003

3. Comparative in vitro activities of carbapenem L-749,345 and other antimicrobials against multiresistant gram-negative clinical pathogens.;Jacoby;Antimicrob Agents Chemother,1997

4. In-vitro antimicrobial activity of a carbapenem, MK-0826 (L-749,345) and provisional interpretive criteria for disc tests.;Fuchs;J Antimicrob Chemother,1999

5. Activity of ertapenem (MK-0826) versus Enterobacteriaceae with potent beta-lactamases.;Livermore;Antimicrob Agents Chemother,2001

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A potential strategy against clinical carbapenem-resistant Enterobacteriaceae: antimicrobial activity study of sweetener-decorated gold nanoparticles in vitro and in vivo;Journal of Nanobiotechnology;2023-11-06

2. Hidradenitis Suppurativa in Children and Adolescents: An Update on Pharmacologic Treatment Options;Pediatric Drugs;2023-10-02

3. A Potential Strategy against Clinical Carbapenem-Resistant Enterobacteriaceae: Antimicrobial Activity Study of Sweetener-Decorated Gold Nanoparticles in Vitro and in Vivo;2023-09-01

4. Exploring the advancements of Australian OPAT;Therapeutic Advances in Infectious Disease;2023-01

5. Effectiveness of ertapenem for treatment of infections in children: An evidence mapping and meta-analysis;Frontiers in Pediatrics;2022-10-12